Kristina Burow
SlowingNamed in filings at ARCH Venture PartnersOn the current fund
- Board seats filed
- 19
Named in filings at ARCH Venture PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Metsera | Biotech & pharma | November 2024 | None on file |
| Autobahn Therapeutics | Biotech & pharma | June 2024 | None on file |
| Mirador Therapeutics | Biotech & pharma | December 2023 | None on file |
| Treeline Biosciences | Biotech & pharma | April 2021 | Aisling Capital, Orbimed Asia Partners, Orbimed Genesis |
| Neumora Therapeutics | Biotech & pharma | September 2020 | None on file |
| Vividion Therapeutics | Biotech & pharma | April 2019 | Nextech Viii Carry Scsp, Versant Venture Capital |
| Boundless Bio | Biotech & pharma | August 2018 | None on file |
| Vir Biotechnology | Biotech & pharma | June 2018 | None on file |
| Beam Therapeutics | Biotech & pharma | February 2018 | Aditum Bio |
| Gossamer Bio | Biotech & pharma | January 2018 | None on file |
| Scholar Rock Holding | Biotech & pharma | December 2017 | Polaris Partners |
| TRELYS | Real estate & proptech | March 2017 | None on file |
| Boragen | Food & agriculture | March 2017 | None on file |
| Unity Biotechnology | Biotech & pharma | October 2016 | None on file |
| Scholar Rock | Biotech & pharma | December 2015 | Polaris Partners |
| Sienna Biopharmaceuticals | Biotech & pharma | October 2015 | None on file |
| Metacrine | Biotech & pharma | January 2015 | Polaris Partners, Venbio Global Strategic, Venbio Select |
| LYCERA | Biotech & pharma | March 2014 | Aditum Bio |
| Receptos | Biotech & pharma | February 2012 | Polaris Partners |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Kristina Burow on the board, based on 19 filed seats with a verified or cited source.